IHVN conducted sensitization exercises amongst health care providers in a hub and spoke model to increase demand for Genexpert TB assays across 30 sites in 5 states of Nigeria.
FIKIA identified children at TB risk and improved diagnosis and provision of preventive treatment through the management of children with household exposure to TB patients and contact investigation.
Private Medicine Vendors are trained to collect sputum samples and send them to the Zankli Research Center for GeneXpert TB tests.
Each screening center is equipped with digital X-ray and GeneXpert systems that offer low-cost, high-quality exams.
The main focus of the project was to improve screening, diagnosis and linkage to treatment in pediatric and perinatal TB.
Ashakalp provided the last mile between availability and accessibility through its CHWs to connect people to the diagnostics and treatment infrastructure to ensure increased TB case notification.